DB:8C4

Stock Analysis Report

Executive Summary

CYBERDYNE Inc. manufactures and sells medical devices in Japan and internationally.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.


Similar Companies

Share Price & News

How has CYBERDYNE's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.8%

8C4

2.5%

DE Medical Equipment

1.2%

DE Market


1 Year Return

0.9%

8C4

18.4%

DE Medical Equipment

8.5%

DE Market

Return vs Industry: 8C4 underperformed the German Medical Equipment industry which returned 18.4% over the past year.

Return vs Market: 8C4 underperformed the German Market which returned 8.5% over the past year.


Shareholder returns

8C4IndustryMarket
7 Day1.8%2.5%1.2%
30 Day1.2%3.1%3.6%
90 Day15.9%0.04%3.5%
1 Year0.9%0.9%20.3%18.4%11.9%8.5%
3 Year-57.4%-57.4%104.0%98.7%19.2%8.8%
5 Year-52.0%-52.0%265.2%246.7%42.0%22.7%

Price Volatility Vs. Market

How volatile is CYBERDYNE's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is CYBERDYNE undervalued compared to its fair value and its price relative to the market?

3.29x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 8C4's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 8C4's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 8C4 is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: 8C4 is unprofitable, so we can't compare its PE Ratio to the German market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 8C4's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 8C4 is good value based on its PB Ratio (3.3x) compared to the DE Medical Equipment industry average (5.8x).


Next Steps

Future Growth

How is CYBERDYNE forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

72.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 8C4 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).

Earnings vs Market: 8C4 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 8C4's is expected to become profitable in the next 3 years.

Revenue vs Market: 8C4's revenue (33.8% per year) is forecast to grow faster than the German market (5% per year).

High Growth Revenue: 8C4's revenue (33.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 8C4's Return on Equity is forecast to be low in 3 years time (1.1%).


Next Steps

Past Performance

How has CYBERDYNE performed over the past 5 years?

16.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 8C4 is unprofitable, but has reduced losses over the past 5 years at a rate of 16.9% per year.

Accelerating Growth: Unable to compare 8C4's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 8C4 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.4%).


Return on Equity

High ROE: 8C4 has a negative Return on Equity (-0.66%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: 8C4 is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: 8C4 is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is CYBERDYNE's financial position?


Financial Position Analysis

Short Term Liabilities: 8C4's short term assets (¥30.3B) exceeds its short term liabilities (¥466.0M)

Long Term Liabilities: 8C4's short term assets (30.3B) exceeds its long term liabilities (1.3B)


Debt to Equity History and Analysis

Debt Level: 8C4 is debt free.

Reducing Debt: 8C4 has no debt compared to 5 years ago when its debt to equity ratio was 49.8%.


Balance Sheet

Inventory Level: 8C4 has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if 8C4's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 8C4 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 8C4 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 68.9% each year


Next Steps

Dividend

What is CYBERDYNE's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.4%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 8C4's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 8C4's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 8C4's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 8C4's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 8C4's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

What is the CEO of CYBERDYNE's salary, the management and board of directors tenure and is there insider trading?

10.7yrs

Average board tenure


CEO

Yoshiyuki Sankai (61yo)

13.7yrs

Tenure

0

Mr. Yoshiyuki Sankai has been the President and Chief Executive Officer of CYBERDYNE Inc. since February 2006 and also serves as its Chairman. Mr. Sankai established CYBERDYNE, Inc. in June 2004. He has be ...


Board Age and Tenure

10.7yrs

Average Tenure

59yo

Average Age

Experienced Board: 8C4's board of directors are seasoned and experienced ( 10.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Yoshiyuki Sankai (61yo)

    Chairman

    • Tenure: 13.7yrs
  • Fumiyuki Ichihashi (41yo)

    Team Leader of Information Strategy Team & Director

    • Tenure: 15.3yrs
  • Shinji Uga (49yo)

    Head of Corporate Unit & Director

    • Tenure: 10.7yrs

Board Members

  • Cees Vellekoop (63yo)

    Outside Audit & Supervisory Board Member

    • Tenure: 12.3yrs
  • Hikari Imai (70yo)

    Outside Director

    • Tenure: 4.3yrs
  • Kazumasa Yoshida (61yo)

    Outside Director

    • Tenure: 6.3yrs
  • Kenichiro Okamura (48yo)

    Outside Audit & Supervisory Board Member

    • Tenure: 8.3yrs
  • Yoshiyuki Sankai (61yo)

    Chairman

    • Tenure: 13.7yrs
  • Fumiyuki Ichihashi (41yo)

    Team Leader of Information Strategy Team & Director

    • Tenure: 15.3yrs
  • Shinji Uga (49yo)

    Head of Corporate Unit & Director

    • Tenure: 10.7yrs
  • Hiroaki Kawamoto (45yo)

    Director

    • Tenure: 15.3yrs
  • Kinichi Nakata (57yo)

    Outside Director

    • Tenure: 11.3yrs
  • Yutaka Fujitani (66yo)

    Outside Audit & Supervisory Board Member (Full-Time)

    • Tenure: 8.3yrs

Company Information

CYBERDYNE Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CYBERDYNE Inc.
  • Ticker: 8C4
  • Exchange: DB
  • Founded: 2004
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: JP¥146.081b
  • Listing Market Cap: JP¥1.209b
  • Shares outstanding: 215.14m
  • Website: https://www.cyberdyne.jp

Number of Employees


Location

  • CYBERDYNE Inc.
  • 2-2-1, Gakuen-Minami
  • Tsukuba
  • Ibaraki
  • 305-0818
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7779TSE (The Tokyo Stock Exchange)YesCommon SharesJPJPYMar 2014
8C4DB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2014
CYBQ.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMar 2014
CYBQ.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDOct 2015

Biography

CYBERDYNE Inc. manufactures and sells medical devices in Japan and internationally. The company offers Hybrid Assistive Limb (HAL) for medical use, living support, and care/labor support; HAL peripherals;  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 21:35
End of Day Share Price2019/10/23 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.